×

Access all guidelines and regulatory updates on

QuriousRI
×

Access all guidelines and regulatory updates on

QuriousRI

Artixio

European Union

European Union Regulatory Affairs Consulting Services

Expert EU regulatory compliance consulting company guiding life sciences businesses through complex regulatory and approval frameworks. Holistic product lifecycle management from inception to product launch and post-marketing surveillance, Artixio offers complete solutions.

EU Regulatory Affairs and Documentation Services

The EU regulatory environment is strict. Companies placing products on the EU market must follow detailed requirements. Regulatory work often continues after approval and does not end with a submission. This is common for pharmaceuticals, medical devices, cosmetics, biologics, and food products. Our EU regulatory affairs consulting services assist with these activities throughout the product lifecycle.

Over the decades, Artixio has leveraged its deep expertise in the industry to successfully introduce the product into the market by adhering to the legal framework in the European Union.

Regulatory Bodies in the European Union

The European Medicine Agency (EMA) is a centralised authority responsible for overseeing the quality and safety aspects of all life science products. A decentralised system under EMA, comprising a National Competent Authority (NCA) within each member state, governs regulations concerning medical devices and regulates the legal framework for the import of life science products.
Key Authorities:

Regulatory Compliance Process for Market Access in EU

Pre-Registration

Registration

Post-Registration

Our Services

Regulatory Affairs
Product Registration
Market Access
IND (Investigational New Drug)
NDA (New Drug Application)
Regulatory Operations
Technical Writing
Regulatory Strategy
Market Access

Why Choose Us for European Regulatory Consulting Services?

Integrated service covering the complete product lifecycle
Expertise in the EU regulatory framework with 15-35 years of experience
Flexible Business Model to suit the client's requirements
AI-driven, regulatory services supported by QuriousRI
ISO 9001:2015 regulatory services
Customer-centric, flexible services and solutions.

FAQs

What are the key components of a regulatory submission dossier in the EU?
EU submission follows a standard Common Technical Document format including: Regional Administrative Information (EU-specific), Overview and summaries, Quality (CMC), Non-clinical study reports and Clinical study reports
The EMA extends support with incentives such as fee reductions or waivers, regulatory guidance, and scientific guidance to SMEs based in the EU.
Decentralized Procedure (DCP) is applicable when a product has not yet been authorized in any EU country and the applicant wishes to obtain authorization in several EU countries simultaneously.
Mutual Recognition Procedure (MRP) is applicable when a product has already been authorized in one EU country and the applicant wants to extend it to other EU member states.

Industries We Serve in the European Union

Pharmaceuticals

MedTech

Cosmetics

Nutrition

Biologics

Veterinary

Our Global Reach: Serving Life
Sciences Clients Worldwide

India

Singapore

Mexico

Brazil

Vietnam

Malaysia

Argentina

Colombia

Taiwan

China

Europe

Thailand

Indonesia

Philippines

USA

Japan

Qatar

South Korea

Insights from Artixio - Tips & Articles

EMA’s Clinical Trial Regulations (EUCTR) in European Union

EMA’s Clinical Trial Regulations

The new EU Clinical Trial Regulation (CTR) 536/2014, which came into effect on January...

February 3, 2026
Role of PRRC under EU MDR and IVDR

Role of PRRC under

Compliance under EU MDR and IVDR is no longer managed in fragments. Instead, accountability...

February 2, 2026
Meeting EU Regulations: Role of the European Authorized Representative (EAR)

Meeting EU Regulations: Role

Placing a medical device on the EU market involves shared responsibility. For manufacturers outside...

February 2, 2026